(Q46471556)

22 December 2017

title

Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis (English)

1 reference

22 December 2017

Mycobacterium tuberculosis

main subject

0 references

1 reference

1 reference

0 references

Rodríguez JC

1

1 reference

22 December 2017

Cebrián L

2

1 reference

22 December 2017

Ruiz M

3

1 reference

22 December 2017

López M

4

1 reference

22 December 2017

Royo G

5

1 reference

22 December 2017

publication date

4 May 2005

1 reference

22 December 2017

published in

Chemotherapy

1 reference

22 December 2017

volume

51

1 reference

22 December 2017

issue

2-3

1 reference

22 December 2017

page(s)

76-79

1 reference

22 December 2017

Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control

cites work

1 reference

Update treatment of multidrug-resistant tuberculosis. Introduction, discussion and summary.

21 January 2018

1 reference

Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival

21 January 2018

1 reference

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis

21 January 2018

1 reference

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

21 January 2018

1 reference

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis

21 January 2018

1 reference

Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis

21 January 2018

1 reference

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine

21 January 2018

1 reference

Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.

21 January 2018

1 reference

Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid

21 January 2018

1 reference

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]

21 January 2018

1 reference

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

Rifampin preventive therapy for tuberculosis in Boston's homeless.

21 January 2018

1 reference

The clinical pharmacokinetics of rifabutin

21 January 2018

1 reference

Use of rifabutin in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000085613

1 reference

22 December 2017

1 reference

22 December 2017